Bionano Genomics Inc (NAS:BNGO)
$ 0.904 -0.026 (-2.8%) Market Cap: 62.47 Mil Enterprise Value: 49.37 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Q3 2019 Bionano Genomics Inc Earnings Call Transcript

Nov 07, 2019 / 09:30PM GMT
Release Date Price: $10.2 (+13.46%)
Operator

Good day, everyone, and welcome to the Bionano Genomics third-quarter 2019 earnings conference call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Ashley Robinson from investor relations.

Ashley Robinson
Bionano Genomics, Inc. - IR, LifeSci Advisors, LLC

Thank you, Lynette, and thank you, operator, and good afternoon, everyone. Welcome to the Bionano Genomics third-quarter 2019 and financial results conference call. Leading the call today will be Dr. Erik Holmlin, CEO of Bionano, and Mike Ward, Bionano's Chief Financial Officer.

After market close today, Bionano issued a press release announcing its financial results for the third quarter of 2019. A copy of the release can be found on the investor relations page of the Company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may contain forward-looking statements, including statements about our strategic and commercialization plans, expectations regarding the rate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot